Circulating Mi-RNA Associated With Disease Severity and Outcome in COVID-19 Patients
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), induces a spectrum of clinical conditions ranging from asymptomatic infection to life threatening severe disease, characterized by respiratory failure, shock and multi-organ dysfunction requiring admission in the intensive care unit (ICU). The aim of the present study is to analyze miRNAs associated with SARS-CoV-2 infection, disease severity and mortality.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• 18 years
• diagnosis of SARS-CoV-2 infection confirmed by molecular testing on nasopharyngeal swabs
Locations
Other Locations
Italy
Fondazione Policlinico Universitario A. Gemelli IRCCS
RECRUITING
Roma
Time Frame
Start Date: 2020-03-01
Estimated Completion Date: 2027-12-01
Participants
Target number of participants: 49
Treatments
Mild Respiratory Failure Covid-19
Patients with Covid-19 and mild respiratory failure defined as PaO2/FiO2 201-300 mm Hg
Severe Respiratory Failure Covid-19
Patients with Covid-19 and severe respiratory failure defined as PaO2/FiO2 ≤100 mm Hg.
Related Therapeutic Areas
Sponsors
Leads: Fondazione Policlinico Universitario Agostino Gemelli IRCCS